Search Ontology:
ChEBI

1-[(9Z)-hexadecenoyl]-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine

Term ID
CHEBI:84816
Synonyms
  • (2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propyl 2-(trimethylammonio)ethyl phosphate
  • 1-Palmitoleoyl-2-arachidonoyl-sn-glycero-3-phosphocholine
  • 13.Phosphatidylcholine(16:1n7/20:4n6)
  • GPCho(16:1/20:4)
  • GPCho(16:1n7/20:4n6)
  • GPCho(16:1w7/20:4w6)
  • GPCho(36:5)
  • PC(16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
  • PC(16:1/20:4)
  • PC(16:1n7/20:4n6)
  • PC(16:1w7/20:4w6)
  • Phosphatidylcholine(16:1/20:4)
  • Phosphatidylcholine(16:1w7/20:4w6)
Definition
A phosphatidylcholine 36:5 in which the acyl groups specified at positions 1 and 2 are (9Z)-hexadecenoyl and (5Z,8Z,11Z,14Z)-eicosatetraenoyl respectively.
References
  • HMDB:HMDB0008015
  • LIPID_MAPS_instance:LMGP01010695
Ontology
ChEBI  ( EBI )
Relationships
is a type of
has_functional_parent
has_role
Phenotype
Phenotype resulting from 1-[(9Z)-hexadecenoyl]-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine
Phenotype where environments contain 1-[(9Z)-hexadecenoyl]-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine
Phenotype modified by environments containing 1-[(9Z)-hexadecenoyl]-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine
Human Disease Model